Brain Tumor Diagnosis and Therapeutics Market Size, Share & Trends Analysis Report By Technology, By Product, By Application, And Segment Forecasts, 2022 – 2027 | GE Healthcare, Hitachi, Philips Healthcare

The Brain Tumor Diagnosis and Therapeutics Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. The market report additionally gives a to-the-point evaluation of the techniques and plans of action that are being executed by the players and companies to contribute to the Brain Tumor Diagnosis and Therapeutics market growth.

The Global Brain Tumor Diagnosis and Therapeutics Market Size is Projected to Reach at a CAGR of 24% during 2022-2027.

Click Here to Get a Free Sample Copy (Exclusive Offer: Flat 20% Discount for A Limited Time):

https://www.marketintelligencedata.com/reports/652973/global-and-china-brain-tumor-diagnosis-and-therapeutics-market-size-status-and-forecast-2021-2027/inquiry?Mode=Rukaiyya

Market Overview

The growth is attributed to the growing burden of brain tumours, raising awareness and increasing R&D on cancer therapeutics. A brain tumour occurs when abnormal cells form within the brain. There are two major types of tumours, malignant or cancerous tumours and benign tumours. The treatment for brain tumours differs depending on several factors, such as age, general health, and the size, location, and type of tumour. However, the high cost of cancer therapy and side effects associated with brain tumour therapeutics are projected to hamper the market growth over the forecast period.

Top Leading Companies:

GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co., AstraZeneca, Bristol Myer Squibb, Novartis, Roche Diagnostics

Recent Development:

GE Healthcare has acquired 29 companies, including 6 in the last 5 years. A total of 11 acquisitions came from private equity firms. It has also divested 11 assets. GE Healthcare’s largest acquisition to date was in 2021 when it acquired BK Medical Holding Company for $1.5B. Its largest disclosed sale occurred in 2018 when it sold Centricity Contingent Staffing to Veritas Capital for $1.1B. GE Healthcare has acquired in 11 different US states, and 5 countries. The Company’s most targeted sectors include medical products (41%) and healthcare services (19%).

Hitachi has acquired 16 companies, including 4 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 5 assets. Hitachi’s largest acquisition to date was in 2021 when it acquired Thales’s Ground Transportation Systems for $1.9B. Its largest disclosed sale occurred in 2011 when it sold HGST to Western Digital for $4.3B. Hitachi has acquired in 4 different US states, and 10 countries. The Company’s most targeted sectors include information technology (38%) and business services (13%).

Brain Tumor Diagnosis and Therapeutics Market Segmentation by Type:

MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG

Brain Tumor Diagnosis and Therapeutics Market Segmentation by Application:

Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy

Explore Full Report with Detailed TOC Here:

https://www.marketintelligencedata.com/reports/652973/global-and-china-brain-tumor-diagnosis-and-therapeutics-market-size-status-and-forecast-2021-2027?Mode=Rukaiyya

We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need.

The United States is Expected to Retain the Largest Market Share During the Forecast Period

The North American brain tumour market is projected to have a significant share over the forecast period. The United States is anticipated to lead the market, this is attributed to the developed healthcare industry, coupled with rising awareness regarding advanced technologies among the population in this region. According to the American Cancer Society, about 23,890 malignant tumours of the brain or spinal cord (13,590 in males and 10,300 in females) will be diagnosed in 2020. Furthermore, the same report stated that about 18,020 people (10,190 males and 7,830 females) will die from brain and spinal cord tumours in 2020.  Moreover, meningioma is the most common form of brain tumour, followed by gliomas. Eflornithine is designated as an orphan drug in the United States and received the breakthrough therapy designation for the treatment of anaplastic glioma. This is likely to positively impact the growth of the market over the forecast period.

Regional Brain Tumor Diagnosis and Therapeutics Market (Regional Output, Demand & Forecast by Countries)

North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Ecuador, Chile)
Asia Pacific (China, Japan, India, Korea)
Europe (Germany, UK, France, Italy)
Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And additional.

Buy Full Report Here:

https://www.marketintelligencedata.com/report/purchase/652973?mode=su?Mode=Rukaiyya

Highlights of the Brain Tumor Diagnosis and Therapeutics Market Report:

Detailed overview of Brain Tumor Diagnosis and Therapeutics Market
Changing the Brain Tumor Diagnosis and Therapeutics market dynamics of the industry
In-depth market segmentation by Type, Application, etc.
Historical, current and projected Brain Tumor Diagnosis and Therapeutics market size in terms of volume and value
Recent industry trends and developments
Competitive landscape of Brain Tumor Diagnosis and Therapeutics Market
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth.

The research includes historic data from 2016 to 2022 and forecasts until 2027 which makes the report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, the Brain Tumor Diagnosis and Therapeutics Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. Brain Tumor Diagnosis and Therapeutics industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.

We Offer Customization on Report Based on Specific Client Requirement:

– Free country Level analysis for any 5 countries of your choice.

– Free Competitive analysis of any 5 key market players.

– Free 40 analyst hours to cover any other data point.

ABOUT US:

Market intelligence data is a global front-runner in the research industry, offering customers contextual and data-driven research services. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – Market Intelligence information

Phone: + 1704 266 3234 | Mob: +91-750-707-8687

sales@marketinsightsreports.com  | irfan@marketinsightsreports.com

This release was published on openPR.